Hela Pharma AB, a prominent player in the pharmaceutical industry, is headquartered in Sweden (SE) and operates extensively across Europe. Founded in 2005, the company has established itself as a leader in the development and manufacturing of high-quality generic pharmaceuticals and innovative healthcare solutions.
Hela Pharma's core offerings include a diverse range of prescription medications, with a focus on therapeutic areas such as oncology, cardiology, and infectious diseases. What sets Hela Pharma apart is its commitment to rigorous quality standards and a robust research and development framework, ensuring that their products meet the highest efficacy and safety benchmarks.
With a strong market position, Hela Pharma AB has achieved significant milestones, including numerous product launches and strategic partnerships that enhance its competitive edge in the pharmaceutical landscape.
+70 vs industry average
Hela Pharma AB’s score of 82 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Hela Pharma AB?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Seafood Production has above-average carbon intensity
Industry performance
The Seafood Production industry has reduced its overall emissions by 37% since 2019
Reported emissions
No reported emissions data is available for Hela Pharma AB yet.
Hela Pharma AB's reported carbon emissions
Hela Pharma AB, headquartered in Sweden (SE), currently does not report specific carbon emissions data, as no emissions figures are available. The company is a current subsidiary of Midsona AB (publ), which may influence its climate commitments and reporting practices.
While Hela Pharma AB has not set explicit reduction targets or climate pledges, it is important to note that its parent company, Midsona AB (publ), is involved in various sustainability initiatives. These initiatives include commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP), which are aimed at reducing carbon footprints and enhancing transparency in climate-related performance.
As a subsidiary, Hela Pharma AB may align its climate strategies with those of Midsona AB (publ), potentially benefiting from the parent company's established sustainability framework. However, specific details regarding Hela Pharma's individual commitments or performance metrics remain unspecified.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Hela Pharma AB’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Hela Pharma AB yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Midsona AB (publ)
Carbon Disclosure Project
Inherited from Midsona AB (publ)
The Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Midsona AB (publ)
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Hela Pharma AB yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project